MSH2 and endometrial carcinoma: Our study corroborates Kempers’ observations, specifically patient #12 from family 5, the carrier of an EPCAM deletion of exons 8 and 9 extending very close to the promotor region of MSH2, who presented both colorectal and endometrial carcinomas.